MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0119757
Desert Pharma Private Limited
Desert Pharma Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15,400
▲ 10% YoY
Net loss · FY 2025
₹1,100
Net margin -7.1%
EBITDA · FY 2025
-₹1,100
EBITDA margin -7.1%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹19 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Desert Pharma Private Limited
Data last updated:
Desert Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India, a subsidiary of Bhanaji Solar Power Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC190697.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹19 Lakh. It is led by directors Nitin Murlidhar Agrawal and Murlidhar Suganchand Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 3 Paithankar Road Itwari Anaj Bazar, Nagpur, Maharashtra, India – 440002.
As per the financials filed for FY 2025, the company reported a revenue of ₹15,400, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹1,100 (net margin -7.1%) and EBITDA of -₹1,100 (EBITDA margin -7.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over five years.
Desert Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0119757). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100MH2009PTC190697
Registration Number 190697
Incorporation Date 04 March 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Bhanaji Solar Power Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0119757
Recognitions & Rankings of Desert Pharma
Contact details
Desert Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressD – 3 Paithankar Road Itwari Anaj Bazar, Nagpur, Maharashtra, India – 440002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Desert Pharma Private Limited, buy the company report.
Comprehensive company report
Desert Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Desert Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Desert Pharma Private Limited, buy the company report.
Financials of Desert Pharma Private Limited
FY 2025 filings availableDesert Pharma Private Limited reported revenue of ₹15,400 (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹15,400 ▲ 10%
Net loss · FY 2025
₹1,100 margin -7.1%
EBITDA · FY 2025
-₹1,100 margin -7.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 59%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 10% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,100 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,100 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.1% | ||||
| Net Profit Margin | -7.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Desert Pharma Private Limited, buy the company report.
Board of directors of Desert Pharma Private Limited
Desert Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Murlidhar Agrawal Also directs: VSR Steel Fabricators Private Limited, Mittal Infraventures Private Limited, Priority Exports Private Limited and 3 more | Director | 02 May 2013 | 13 Years 5 Months | Current |
| Murlidhar Suganchand Agrawal Also directs: VSR Steel Fabricators Private Limited, Mittal Infraventures Private Limited, Priority Exports Private Limited and 2 more | Director | 02 May 2013 | 13 Years 5 Months | Current |
Auditor
Desert Pharma Private Limited is audited by SAJJAD RASUL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAJJAD RASUL & CO | FY 2020 | 120594W |
Shareholding
The shareholding of Desert Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Desert Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Desert Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Desert Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Desert Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Desert Pharma Private Limited has 11 board changes on record since 2011: 2 appointments and 9 cessations. The latest: Vikas Jain ceased to be Director on 18 Jul 2013.
AGM
Desert Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Desert Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Vikas Jain ceased to be Director.
Appointed
Murlidhar Suganchand Agrawal was appointed as Director.
Appointed
Nitin Murlidhar Agrawal was appointed as Director.
Ceased
Vipin Kumar Sanklecha ceased to be Director.
Ceased
Rima Bhandari ceased to be Director.
Ceased
Suparas Bhandari ceased to be Director.
Ceased
Gamna Ram ceased to be Director.
Ceased
Indira Dhariwal ceased to be Director.
Ceased
Manohar Das ceased to be Director.
Ceased
Padamraj Tarachand Desarla ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Desert Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 March 2009 (17+ years old) and is registered under CIN U24100MH2009PTC190697.
Desert Pharma has 2 current directors:
- Nitin Murlidhar Agrawal - Director
- Murlidhar Suganchand Agrawal - Director
The latest financial statements of Desert Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Desert Pharma is U24100MH2009PTC190697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Desert Pharma was incorporated on 04 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Vikas Jain ceased to be Director on 18 Jul 2013. Murlidhar Suganchand Agrawal was appointed as Director on 02 May 2013. Nitin Murlidhar Agrawal was appointed as Director on 02 May 2013. Desert Pharma has 11 board changes on record in total.
Yes, Desert Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0119757).
The registered office of Desert Pharma is at D – 3 Paithankar Road Itwari Anaj Bazar, Nagpur, Maharashtra, India – 440002.
Desert Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Desert Pharma is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.